Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Autor: Ma Socinski, Sp Myrand, J. von Pawel, Aleksandra Szczesna, Giorgio V. Scagliotti, Bp Mullaney, Nick Thatcher, Sc Guba, Na Karaseva, Martin Reck, Rr Hozak, E. Powell, Ef Smit, Tudor-Eliade Ciuleanu, Paul Lorigan, S Hong, D Ohannesian

Publikováno v: Smit, E F, Socinski, M, Mullaney, B, Myrand, S, Scagliotti, G V, Lorigan, P, Reck, M, Ciuleanu, T, van Pawel, J, Karaseva, N, Szczesna, A, Ohannesian, D, Powell, E, Hozak, R, Hong, S, Guba, S & Thatcher, N 2012, ' Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer ', Annals of Oncology, vol. 23, no. 7, pp. 1723-1729 . https://doi.org/10.1093/annonc/mdr563
Annals of Oncology, 23(7), 1723-1729. Oxford University Press

Background Clinical results of a randomized phase III trial comparing pemetrexed-carboplatin (PC) with etoposide-carboplatin (EC) in chemonaive patients with extensive-stage disease small-cell lung cancer (ED-SCLC) resulted in trial closure for futil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876335ea495a4ca1a70a62600c4c29fe
https://research.vumc.nl/en/publications/3cd0fa52-338d-40ee-85c6-45a87fd3b3cc

PHASE-I STUDY OF HIGH-DOSE EPIRUBICIN AND VINORELBINE IN PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER STAGE IIIB-IV

Autor: Bakker, M., Harry J.M. Groen, Ef, Smit, Smeets, J., Riggi, M., Pieter Postmus

Publikováno v: British Jounal of Cancer, 72(6), 1547-1550. Nature Publishing Group
University of Groningen

The aim of the study was to determine the maximum tolerated dose (MTD) for the combination of high-dose epirubicin and vinorelbine in chemotherapy-naive patients with inoperable non-small-cell lung cancer (NSCLC). Twenty-one patients with stage IIIB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bfe6e889326b332a2d8121ef3ecb7227
https://research.rug.nl/en/publications/89e27b52-b6f3-4c24-a0df-e067d4442ea2

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

Autor: S Trebeschi, SG Drago, NJ Birkbak, I Kurilova, AM Cǎlin, A Delli Pizzi, F Lalezari, DMJ Lambregts, MW Rohaan, C Parmar, EA Rozeman, KJ Hartemink, C Swanton, JBAG Haanen, CU Blank, EF Smit, RGH Beets-Tan, HJWL Aerts

INTRODUCTION: Immunotherapy is regarded one of the major breakthroughs in cancer treatment. Despite its success, only a subset of patients responds - urging the quest for predictive biomarkers. We hypothesize that Artificial Intelligence (AI) algorit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::edace40fc60729c94d50df10fede3ad0

The natural course of preneoplastic lesions in bronchial epithelium

Autor: Rh, Breuer, Pasic A, Ef, Smit, van Vliet E, Vonk Noordegraaf A, Ej, Risse, pieter postmus, Tg, Sutedja

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::340836d9819a9e0b29908c786257301d
http://europepmc.org/abstract/med/15701838

SURGICAL RESECTION FOR SMALL-CELL CARCINOMA OF THE LUNG - A RETROSPECTIVE STUDY

Autor: EF SMIT, Groen, Harry J. M., Wim Timens, PE POSTMUS

Publikováno v: University of Groningen
Thorax, 49(1), 20-22. BMJ PUBLISHING GROUP

Background - A retrospective review was undertaken of the survival of 21 patients with histologically proven small cell carcinoma of the lung resected between 1977 and 1991. Methods - Twenty one patients (20 men) of median age 60 (range 44-73) years

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8b14e8938b7c5fa08dda0b83ef277831
https://research.rug.nl/en/publications/9119270a-a0b0-48f8-8e7d-c44153dcabe8